These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16798274)

  • 1. Insulin resistance in women with polycystic ovary syndrome.
    Dunaif A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S13-4. PubMed ID: 16798274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.
    Urbanek M; Sam S; Legro RS; Dunaif A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4191-8. PubMed ID: 17785364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.
    Corbould A; Kim YB; Youngren JF; Pender C; Kahn BB; Lee A; Dunaif A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1047-54. PubMed ID: 15613682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.
    Corbould A; Zhao H; Mirzoeva S; Aird F; Dunaif A
    Diabetes; 2006 Mar; 55(3):751-9. PubMed ID: 16505239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
    Dunaif A; Xia J; Book CB; Schenker E; Tang Z
    J Clin Invest; 1995 Aug; 96(2):801-10. PubMed ID: 7635975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome: syndrome XX?
    Sam S; Dunaif A
    Trends Endocrinol Metab; 2003 Oct; 14(8):365-70. PubMed ID: 14516934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
    Corbould A; Dunaif A
    Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective insulin resistance in the polycystic ovary syndrome.
    Book CB; Dunaif A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3110-6. PubMed ID: 10487672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome].
    Wu XK; Risto E
    Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):804-8. PubMed ID: 15733404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in the polycystic ovary syndrome.
    Dunaif A; Thomas A
    Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
    Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
    Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).
    Dunaif A; Wu X; Lee A; Diamanti-Kandarakis E
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E392-9. PubMed ID: 11440917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
    Mukherjee S; Maitra A
    Indian J Med Res; 2010 Jun; 131():743-60. PubMed ID: 20571162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
    Diamanti-Kandarakis E; Dunaif A
    Endocr Rev; 2012 Dec; 33(6):981-1030. PubMed ID: 23065822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription Factor-7-Like 2 Gene Variants Affect the Metabolic Phenotypes of Polycystic Ovary Syndrome.
    Gammoh E; Mahmood NA; Madan S; Ebrahim BH; Mustafa FE; Almawi WY
    Ann Nutr Metab; 2015; 67(4):228-35. PubMed ID: 26536002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives of insulin resistance and polycystic ovary syndrome.
    Pauli JM; Raja-Khan N; Wu X; Legro RS
    Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.